DRTG(SH:600329)2023-10-30 16:00Financial Performance - Q3 2023 revenue was CNY 1,704,730,942.14, a decrease of 4.67% year-on-year[3] - Net profit attributable to shareholders was CNY 135,700,484.58, down 47.84% compared to the same period last year[3] - Net profit excluding non-recurring items was CNY 129,732,558.15, a decrease of 29.64% year-on-year[3] - Basic earnings per share for Q3 2023 was CNY 0.17, down 50.00% year-on-year[4] - Operating profit for Q3 2023 was ¥961,951,114.63, up from ¥850,221,307.98 in Q3 2022, reflecting a growth of 13.1%[22] - Net profit for Q3 2023 amounted to ¥842,024,243.32, compared to ¥746,212,552.88 in Q3 2022, representing an increase of 12.8%[23] - The net profit attributable to the parent company's shareholders for the third quarter of 2023 was ¥858,191,973.18, an increase from ¥728,960,736.26 in the same period of 2022, representing a growth of approximately 17.7%[24] - The total comprehensive income attributable to the parent company's owners for the third quarter of 2023 was ¥730,680,189.05, compared to ¥728,960,736.26 in the previous year, indicating a slight increase[25] Cash Flow - Operating cash flow for Q3 2023 was negative CNY 41,248,808.23, a decline of 210.24% compared to the same period last year[4] - Cash flow from operating activities for the year-to-date period decreased by 35.81% due to increased cash payments for goods and services[8] - The net cash flow from operating activities for the third quarter of 2023 was ¥81,184,927.06, down from ¥126,473,611.63 in the previous year[28] - The company experienced a cash outflow from operating activities totaling ¥6,123,774,533.57 in the third quarter of 2023, compared to ¥5,358,046,176.79 in the previous year, indicating an increase in cash outflow[28] - Cash inflow from operating activities for the first three quarters of 2023 was ¥6,204,959,460.63, up from ¥5,484,519,788.42 in the same period of 2022, reflecting a growth of approximately 13.1%[26] Assets and Liabilities - Total assets at the end of Q3 2023 were CNY 10,281,701,203.62, an increase of 1.23% from the end of the previous year[4] - Shareholders' equity attributable to the parent company was CNY 6,468,059,431.40, a decrease of 0.82% compared to the end of the previous year[4] - Non-current assets totaled ¥3,574,055,050.13, significantly higher than ¥2,911,537,283.18 in the previous year, indicating a growth of 22.7%[19] - Current liabilities increased to ¥3,403,691,200.41 from ¥3,333,434,867.96, marking a rise of 2.1%[19] - Long-term borrowings rose to ¥241,443,385.34, up from ¥151,299,534.67, reflecting a growth of 59.7%[19] Investments and Financing - The decrease in net profit for Q3 was primarily due to reduced investment income[8] - The company reported an investment income of ¥219,396,356.65, compared to ¥208,404,585.16 in the previous year, an increase of 5.7%[22] - The net cash flow from investing activities for the third quarter of 2023 was -¥485,632,788.41, a decrease compared to a positive cash flow of ¥155,484,657.49 in the same period of 2022[28] - The net cash flow from financing activities for the third quarter of 2023 was -¥377,506,781.32, slightly worse than -¥365,254,248.33 in the previous year[28] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 38,363[11] - The largest shareholder, Tianjin Pharmaceutical Group Co., Ltd., holds 331,120,528 shares, accounting for 42.989% of total shares[11] Inventory and Receivables - Inventory increased to 1,674.59 million from 1,429.45 million, representing a growth of about 17.1% year-over-year[17] - Accounts receivable financing decreased by 55.25 million, primarily due to a reduction in bank acceptance bills for sale or discount purposes[10] - Other receivables decreased by 57.06 million, mainly due to the transfer of land use rights deposit from 2022 to intangible assets[10] Financial Expenses - The company reported a financial expense increase of 50.84 million, mainly due to a rise in interest expenses year-over-year[10] - Cash and cash equivalents as of September 30, 2023, were 2,019.89 million, down from 2,882.52 million as of December 31, 2022, reflecting a decrease of approximately 30%[17] - Debt investment rose significantly to 1,457.13 million, primarily due to the purchase of large-denomination certificates of deposit[10]